Results 81 to 90 of about 4,991 (245)
Drug-Induced gingival overgrowth: The genetic dimension
Currently, the etiology of drug-induced gingival overgrowth is not entirely understood but is clearly multifactorial. Phenytoin, one of the common drugs implicated in gingival enlargement, is metabolized mainly by cytochrome P450 (CYP)2C9 and partly by CYP2C19.
Charles, Noronha Shyam Curtis +5 more
openaire +3 more sources
Soft Tissue Substitutes: Current Biomaterials and Indications at Teeth and Implant Sites
This manuscript provides an updated overview of the current evidence on soft tissue graft substitutes for teeth and dental implants. When appropriately indicated, these biomaterials offer a reliable, less invasive alternative to autogenous grafts, effectively improving root coverage, keratinized mucosa width, and soft tissue thickness with reduced ...
Lorenzo Tavelli +4 more
wiley +1 more source
Peri‐Implantitis and Periodontitis: Biological Convergence, Contextual Divergence
Periodontal and peri‐implant tissues differ and coincide in many aspects, from the clinical and radiological perspective, including histology, microbiology, and molecular markers. Thus, health and disease may also follow different and similar routes.
Pablo Galindo‐Moreno +6 more
wiley +1 more source
Gingival overgrowth/hyperplasia can be attributed to several causes, but drug-induced gingival overgrowth/hyperplasia arises secondarily to prolonged use of antihypertensive drugs, anticonvulsants and immunosuppressants.
Tupili Muralikrishna +3 more
doaj +1 more source
Gingival fibroma versus verrucous leukoplakia – A clinical dilemma!!!
Gingival overgrowths found in the oral cavity are mostly due to reactive hyperplasia and rarely depict neoplastic nature. It is a challenge for the clinician to give final diagnoses of gingival overgrowth.
Renu Garg +3 more
doaj +1 more source
CCN2: A potential contributor to gingival overgrowth
Fibrotic responses in the gingiva are characterized by their hyperproliferative nature instead of scar tissue formation. Clinically, these conditions appear as "gingival overgrowth" (GO), which can be of drug-induced or genetic origin. Despite surgical removal, GO can recur. Therefore, non-invasive methods of treating GO are required. In other fibrotic
Asmaa Fadl, Andrew Leask
openaire +2 more sources
Crevicular fluid levels of TGFβ1 in drug-induced gingival overgrowth
OBJECTIVE: To determine if local, gingival crevicular fluid (GCF) levels of TGFbeta1 were altered in drug-induced gingival overgrowth. Patients and methods: GCF samples were collected on Periopaper strips from 45 renal transplant recipients who had been ...
Chapple, Iain; id_orcid +3 more
core +1 more source
A rare case of accelerated gingival overgrowth with high dose amlodipine therapy
Gingival overgrowth represents an over-exuberant response to a variety of local and systemic conditions. Certain anticonvulsants, immunosuppressive drugs, and a number of calcium channel blockers have been shown to produce similar gingival overgrowth in ...
Chandana, K H +2 more
core +1 more source
Resveratrol in repeated doses has been shown to suppress excessive cell proliferation without cytotoxic effects in amlodipine‐induced gingival hyperplasia, while not having a negative effect on mediators involved in tissue homeostasis in healthy cells, and at the same time, it reduces the expression of biomarkers involved in fibrosis processes ...
Bilkan Kara +6 more
wiley +1 more source
Cyclosporine-A Induced Gingival Overgrowth
Background. The link between the gingival overgrowth and cyclosporine pharmacokinetical variables, especially cyclosporine doses which appear to act as stimulator of the gingival proliferative changes, presents a field of interest of large number of ...
K Mitic +7 more
core

